Acadia Healthcare Co Stock Rating Lowered by Citigroup Inc. (ACHC)
Acadia Healthcare Co (NASDAQ:ACHC) was downgraded by equities researchers at Citigroup Inc. from a “buy” rating to a “neutral” rating in a research report issued on Tuesday, TheFlyOnTheWall.com reports. They currently have a $49.00 target price on the stock, up from their previous target price of $43.00. Citigroup Inc.’s price objective points to a potential upside of 1.07% from the stock’s previous close.
Acadia Healthcare Co (NASDAQ:ACHC) traded up 0.21% on Tuesday, hitting $48.48. The stock had a trading volume of 636,724 shares. Acadia Healthcare Co has a 1-year low of $24.18 and a 1-year high of $49.44. The stock has a 50-day moving average of $46.63 and a 200-day moving average of $40.28. The company has a market cap of $2.449 billion and a price-to-earnings ratio of 68.05.
Acadia Healthcare Co (NASDAQ:ACHC) last released its earnings data on Wednesday, October 30th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.02. The company had revenue of $184.70 million for the quarter, compared to the consensus estimate of $179.47 million. The company’s revenue for the quarter was up 79.1% on a year-over-year basis. Analysts expect that Acadia Healthcare Co will post $1.07 EPS for the current fiscal year.
A number of other firms have also recently commented on ACHC. Analysts at Susquehanna initiated coverage on shares of Acadia Healthcare Co in a research note to investors on Tuesday, December 17th. They set a “positive” rating on the stock. Separately, analysts at Zacks upgraded shares of Acadia Healthcare Co from a “neutral” rating to an “outperform” rating in a research note to investors on Tuesday, December 10th. They now have a $49.50 price target on the stock. Finally, analysts at Wells Fargo & Co. initiated coverage on shares of Acadia Healthcare Co in a research note to investors on Friday, December 6th. They set a “market perform” rating on the stock. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Acadia Healthcare Co presently has a consensus rating of “Buy” and an average target price of $43.35.
Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.